Its much better." Although a couple have reported 'fatigue' while taking the drug, one user took to the thread to see if anyone else had been affected by insomnia
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, modulates hunger signals rather than eliminating them entirely
From personal experience, it appears that there is a misconception among some clinicians that DPP-4 inhibitors are essentially orally administered GLP-1RAs
The SURPASS trials, sponsored by pharmaceutical manufacturer Eli Lilly, assessed Mounjaro (tirzepatide) in people with type 2 diabetes and obesity
Top 20 drugs heading for the patent cliff, 2026-2029
Step 1: Verify Your Insurance Begin with a brief intake form that captures your health and insurance information